Skip to main content
. 2022 Aug 25;14(17):4117. doi: 10.3390/cancers14174117

Figure 3.

Figure 3

Forest plots on pooled Hazard Ratios (HRs) on smoking during chemoradiotherapy and efficacy. (a) Smoking during chemoradiotherapy and locoregional recurrence free survival; (b) smoking during chemoradiotherapy and disease-free survival. HR > 1 indicates worse outcome for smokers during radiation treatment, whereas HR < 1 indicates better outcome. Comparison group is non-smoker (former or never). Abbreviation: H&N, head and neck cancer.